Revenue missed analyst estimates by 2.3%. Earnings per share (EPS) exceeded analyst estimates by 4.9%. Looking ahead, revenue is forecast to grow 28% p.a. on average during the next 3 years, compared ...

Q3 2024 Earnings Call Transcript November 13, 2024 Operator: Greetings, and welcome to the electroCore Third Quarter 2024 ...

Maxim Group analyst Anthony Vendetti has reiterated their bullish stance on ECOR stock, giving a Buy rating yesterday. Anthony Vendetti has ...

H.C. Wainwright raised the firm’s price target on electroCore (ECOR) to $22 from $15 and keeps a Buy rating on the shares after the firm ...

Despite achieving its eighth consecutive record revenue quarter, electroCore Inc (ECOR) faces hurdles with net losses and ...

ElectroCore, Inc. (ECOR) came out with a quarterly loss of $0.31 per share versus the Zacks Consensus Estimate of a loss of $0.29. This compares to loss of $0.68 per share a year ago. These figures ...

CloseCurlyDoubleQuote; For the quarter ended September 30, 2024, electroCore reported net sales of $6.6 million compared to $4.5 million during the same period of 2023, which represents an approximate ...

ROCKAWAY, N.J., Nov. 12, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, is proud to announce that its flagship wellness ...

An archived webcast of the event will be available on the “Investors” section of the company’s website at: www.electrocore.com. About electroCore, Inc. electroCore, Inc. is a commercial ...

Greetings, and welcome to the electroCore Third Quarter 2024 Earnings Conference Call. [Operator Instructions] As a reminder, this conference is being recorded. It is now my pleasure to introduce ...

ROCKAWAY, N.J., Nov. 12, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, is proud to announce that its flagship wellness ...